WuXi PharmaTech announced that is has expanded its collaboration with Johnson & Johnson. According to the release, WuXi will provide Janssen Pharmaceutica, a division of J&J Pharmaceutical Research & Development, with integrated research services in the area of discovery chemistry, discovery biology, chemical and analytical development services, formulation, and preclinical and bio-analytical services. More details...

Stock Symbols: (NYSE: WX) (NYSE: JNJ)